Centene reported first quarter 2025 diluted EPS of $2.63 and adjusted diluted EPS of $2.90, representing a 28% increase from $2.26 in the first quarter of 2024.

Premium and service revenue grew 17% year-over-year. Membership rose by 29% in Marketplace plans and 22% in Medicare Prescription Drug Plans (PDP) compared to the prior year period. The company raised its 2025 premium and service revenue guidance by $6.0 billion, citing strong Marketplace enrollment and better-than-expected Medicare member retention.